Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Margaret K. Formica is active.

Publication


Featured researches published by Margaret K. Formica.


American Journal of Public Health | 2017

Academic Public Health and the Firearm Crisis: An Agenda for Action

Charles C. Branas; Andrew Flescher; Margaret K. Formica; Sandro Galea; Nils Hennig; Karen D. Liller; Hala N. Madanat; Andrew Park; John E. Rosenthal; Jun Ying

The authors reflect on the need for members of the academic public health community in America to develop a social action strategy for dealing with a firearms-related crisis in the U.S. as of 2017, and it mentions gun control initiatives, business plans, and statistics regarding firearms-related deaths and suicides in America since 1900. U.S. President Donald Trumps views about gun rights are examined, along with collaborations and firearm research and scholarship in the country.


American Journal of Men's Health | 2017

Cognitive and Affective Representations of Active Surveillance as a Treatment Option for Low-Risk Prostate Cancer

Kathleen Doyle Lyons; Hsin H. Li; Emily M. Mader; Telisa Stewart; Christopher P. Morley; Margaret K. Formica; Scott D. Perrapato; John D. Seigne; Elias S. Hyams; Brian H. Irwin; Terry Mosher; Mark T. Hegel

Benefits of early diagnosis and treatment remain debatable for men with low-risk prostate cancer. Active surveillance (AS) is an alternative to treatment. The goal of AS is to identify patients whose cancer is progressing rapidly while avoiding treatment in the majority of patients. The purpose of this study was to explore cognitive and affective representations of AS within a clinical environment that promotes AS a viable option for men with low-risk prostate cancer. Participants included patients for whom AS and active treatment were equally viable options, as well as practitioners who were involved in consultations for prostate cancer. Data were generated from semistructured interviews and audits of consultation notes and were analyzed using thematic analysis. Nineteen patients and 16 practitioners completed a semistructured interview. Patients generally viewed AS as a temporary strategy that was largely equated with inaction. There was variation in the degree to which inaction was viewed as warranted or favorable. Patient perceptions of AS were generally malleable and able to be influenced by information from trusted sources. Encouraging slow deliberation and multiple consultations may facilitate greater understanding and acceptance of AS as a viable treatment option for low-risk prostate cancer.


Urologic Oncology-seminars and Original Investigations | 2017

Comparison of survival for partial vs. radical nephrectomy in young patients with T1a renal cell carcinoma treated at commission on cancer-accredited facilities and influence of comorbidities on treatment choice

Daniel C. Wang; Kyle Plante; Telisa Stewart; Dongliang Wang; Margaret K. Formica; Michael Daugherty; Gennady Bratslavsky

PURPOSE There is a paucity of data comparing effects of partial nephrectomy (PN) vs. radical nephrectomy (RN) on overall survival in young patients. In this study, the National Cancer Database was used to evaluate the survival outcomes of those treated with PN and RN, and influence of comorbidities on surgical treatment (PN vs. RN) in young patients while accounting for Charlson-Deyo Comorbidity Score (CDCS). MATERIALS AND METHODS Patients between 20 and 44 years old (n = 9,849) surgically treated for pT1a renal cell carcinoma between 2004 and 2013 were identified from the National Cancer Database. Kaplan-Meier log-rank analysis and Cox proportional hazards model were performed to compare overall survival and calculate the hazard ratio between those undergoing RN and PN. Binary logistic regression was used to calculate odds ratios for receiving RN compared to PN. The effect measures in all models were adjusted for potential confounding factors. RESULTS After adjusting for comorbidities, PN offered an overall survival advantage over RN (P<0.001, hazard ratio = 0.464, 95% CI: 0.359-0.601) at a mean follow-up of 48.4 months (0-130.96), including young patients with no comorbidities (P<0.001). Compared to those with a CDCS = 0, patients were more likely to be treated with RN if they had a CDCS>1 (odds ratios = 2.049, 95% CI: 1.527-2.750). CONCLUSIONS Young patients treated with PN demonstrate an overall survival advantage. This survival advantage is observed after an early follow-up even in those without comorbidities. It is still not clear if the survival advantage seen is due to treatment itself or selection bias.


BMC Urology | 2017

Qualitative insights into how men with low-risk prostate cancer choosing active surveillance negotiate stress and uncertainty.

Emily M. Mader; Hsin H. Li; Kathleen Doyle Lyons; Christopher P. Morley; Margaret K. Formica; Scott D. Perrapato; Brian H. Irwin; John D. Seigne; Elias S. Hyams; Terry Mosher; Mark T. Hegel; Telisa Stewart

BackgroundActive surveillance is a management strategy for men diagnosed with early-stage, low-risk prostate cancer in which their cancer is monitored and treatment is delayed. This study investigated the primary coping mechanisms for men following the active surveillance treatment plan, with a specific focus on how these men interact with their social network as they negotiate the stress and uncertainty of their diagnosis and treatment approach.MethodsThematic analysis of semi-structured interviews at two academic institutions located in the northeastern US. Participants include 15 men diagnosed with low-risk prostate cancer following active surveillance.ResultsThe decision to follow active surveillance reflects the desire to avoid potentially life-altering side effects associated with active treatment options. Men on active surveillance cope with their prostate cancer diagnosis by both maintaining a sense of control over their daily lives, as well as relying on the support provided them by their social networks and the medical community. Social networks support men on active surveillance by encouraging lifestyle changes and serving as a resource to discuss and ease cancer-related stress.ConclusionsSupport systems for men with low-risk prostate cancer do not always interface directly with the medical community. Spousal and social support play important roles in helping men understand and accept their prostate cancer diagnosis and chosen care plan. It may be beneficial to highlight the role of social support in interventions targeting the psychosocial health of men on active surveillance.


American Journal of Public Health | 2018

Priorities in Recovering From a Lost Generation of Firearms Research

Sandro Galea; Charles C. Branas; Andrew Flescher; Margaret K. Formica; Nils Hennig; Karen D. Liller; Hala N. Madanat; Andrew Park; John E. Rosenthal; Jun Ying

An editorial is presented which addresses firearms research in America as of 2018, and it mentions gun-related violence in the U.S., media coverage of mass shootings, and school shootings at places such as Marjory Stoneman Douglas High School shooting in Parkland, Florida. Lobbyists for the firearms industry are examined, along with support for gun safety reform. The U.S. Centers for Disease Control and Prevention (CDC) and population health research are assessed.


Patient Education and Counseling | 2017

Impact of a decision aid on newly diagnosed prostate cancer patients’ understanding of the rationale for active surveillance

Margaret K. Formica; Shaun Wason; John D. Seigne; Telisa M. Stewart


International Urology and Nephrology | 2017

Treatment trends, determinants, and survival of partial and radical nephrectomy for stage I renal cell carcinoma: results from the National Cancer Data Base, 2004–2013

Kyle Plante; Telisa Stewart; Dongliang Wang; Gennady Bratslavsky; Margaret K. Formica


Landscape and Urban Planning | 2018

The relationship between self-reported exposure to greenspace and human stress in Baltimore, MD

Meghan Hazer; Margaret K. Formica; Susan Dieterlen; Christopher P. Morley


International Urology and Nephrology | 2018

Pathological upstaging of clinical T1 renal cell carcinoma: an analysis of 115,835 patients from National Cancer Data Base, 2004–2013

Amanda Ghanie; Margaret K. Formica; Dongliang Wang; Gennady Bratslavsky; Telisa Stewart


International Journal of Radiation Oncology Biology Physics | 2018

P08) Retrospective Comparison of Gammaknife Radiosurgery and Hypofractionated Radiotherapy as Treatment Options for Intracranial Metastases Measuring 4cc or Larger

Emily C. Daugherty; Ayesha Ropri; Daniel A. Bassano; Margaret K. Formica; Anna Shapiro; Michael Lacombe; Paul Aridgides; Seung Shin Hahn

Collaboration


Dive into the Margaret K. Formica's collaboration.

Top Co-Authors

Avatar

Telisa Stewart

State University of New York Upstate Medical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Andrew Park

State University of New York Upstate Medical University

View shared research outputs
Top Co-Authors

Avatar

Charles C. Branas

University of Pennsylvania

View shared research outputs
Top Co-Authors

Avatar

Christopher P. Morley

State University of New York Upstate Medical University

View shared research outputs
Top Co-Authors

Avatar

Dongliang Wang

State University of New York Upstate Medical University

View shared research outputs
Top Co-Authors

Avatar

Gennady Bratslavsky

State University of New York Upstate Medical University

View shared research outputs
Top Co-Authors

Avatar

Hala N. Madanat

State University of New York Upstate Medical University

View shared research outputs
Top Co-Authors

Avatar

John E. Rosenthal

State University of New York Upstate Medical University

View shared research outputs
Top Co-Authors

Avatar

Jun Ying

State University of New York Upstate Medical University

View shared research outputs
Researchain Logo
Decentralizing Knowledge